Rajasthan

26 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
24 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
9 April 2015

Applications invited for Pharma Management faculties at IIHMR University

IIHMR University Is a specialised Research University in management research, postgraduate education and training exclusively in the health sector. The IIHMR University has established the discipline of health management and set the national agenda lor policy and program and health systems research in the health sector. It is a WHO Collaborating Centre for district health systems and designated as an Institute of Excedence in India for training and capacity.

Invites Applications For Associate Professor AND Assistant Professor In Following Areas:

Post: Associate Professor, Assistant Professor
6 April 2015

AN INSIGHT ON NUTRACEUTICALS

{ DOWNLOAD AS PDF }
31 March 2015

PharmaTutor Magazine - April 2015 is released | Read online and Subscribe
30 March 2015

Opportunity for Assistant Professor - Pharmacy in MSU

Mohanlal Sukhadia University (erstwhile Udaipur University) at Udaipur is a State University established by an Act in the year 1962 to cater the needs of higher education in Southern Rajasthan. The University is located in Aravalli Hill Area largely dominated by tribal populations. Endowed with rich cultural heritage, natural resources and beautiful landscape, Udaipur is a world renowned tourist attraction.

On-line applications are invited for appointment of teaching faculties on regular basis for the following posts:

Post: Assistant Professor
27 March 2015

Vacancies for B.Pharm/D.Pharm as Logistic Manager, Consultant in National Health Mission

National Health Mission (NHM), Rajasthan State Health Society, invites applications for various positions of Managers/Consultants/Ofificers/Coordinators and Assistants at State HQ on contractual basis under National Rural Health Mission (NRHM) Rajasthan.

The details of various positions, required essential qualifications & experience, maximum age limit etc.are as under:

Post: Logistic Manager, Consultant
2 March 2015

Admission open for MBA Pharmaceutical Management at IIHMR University, Jaipur

The IIHMR University, Jaipur formerly known as Institute of Health Management Research (IIHMR), Jaipur the premier University in Hospital, Health, Pharmaceutical and Rural Management, has made a phenomenal contribution in the career of its alumni. Provides excellent opportunities in education, training, research and consultancy in healthcare and hospital Services.

ENQUIRE TODAY>>

A Unique Research and Postgraduate University in Health Sector Established Under IIHMR Private University Act 2014, Government of Rajasthan
Formerly known as Institute of Health Management Research (IIHMR), Jaipur A WHO Collaborating Centre for District Health Systems based on Primary Health Care

MBA PHARMACEUTICAL MANAGEMENT

Eligibility:
· Recognized Bachelor's Degree in Medicine/Pharmacy/ Biotechnology/Science/Management with at least 50% marks in aggregate.
· Valid Score of CAT/MAT/CMAT/ATMA/XAT/GPAT.
· Working professionals with at least two years experience in Pharmaceutical or Health sector are encouraged to apply and are exempted from the scores of management aptitude tests.

Some of leading recruiters

ENQUIRE TODAY>>

Address:
1, Prabhu Dayal Marg, Sanganer Airport, Jaipur - 302029
Phone: 91-141-3924700, 2791431-32
Fax: 91-141-3924738
28 February 2015

PharmaTutor Magazine - March 2015 is released | Read online and Subscribe

20 February 2015

Global Institute of Regulatory Affairs provides Industry Oriented Courses in Regulatory Affairs (RA), Quality Assurance & Quality Control (QA/QC) for Life Science Graduates with Placement Assisstance in Pharma Sector

Global Institute of Regulatory Affairs provides Industry Oriented Courses in Regulatory Affairs (RA), Quality Assurance & Quality Control (QA/QC) for Life Science Graduates with 100% Placement Assistance in Pharma Sector**
Global Institute of Regulatory Affairs (GIRA) is a change that will help you begin & grow your career in Pharma Industry. GIRA through its industrial expertise offers quality educational programs in the field of Regulatory Affairs and QA/QC. It offers Full time, Part time and Distance Learning courses; this flexibility ensures prior commitments are taken care of and at the same time skills are added to their CVs.

Certifications: GIRA is an ISO Certified Institute as per the norms of ISO 9001:2008. It is accredited by Joint Accreditation System of Australia & New Zealand (JAS-ANZ).

Course name: Certificate Course in e-CTD submission(4 months)

COURSE HIGHLIGHT: 2 days Hands-on Experience on the e-CTD Software (LORENZ DOCUBRIDGE)

2 days Hands-on Experience:

1st Day- A Demo/Step by Step procedure to the Software by the e-CTD expert through a Webinar

2nd Day- Remote access of the software given to the Applicant to practice the e-CTD submission skills

“Special 7 days Online Program- Available only for Working Professionals"

WHO WILL BENEFIT:
• RA Executives responsible for CTD/DMF Compilation & Submission
• QC/QA Managers and Staff
• Documentation department
• Regulatory Consultants
• Pharma Freshers looking for Direct Entry in QA/RA Departments

Program Highlights:
* Completely Online (From Admission to Examination)
* Industry Accepted Course Curriculum & Certificate
* Experienced and Quality Faculty
* Online Examination (Exams from Home)
* Online Interaction (Discussion Forums, GIRA Blog)
* 100 % Placement Assistance & Career Guidance

Candidates Pursuing Courses from GIRA are associated with:
Emcure Pharmaceutical Ltd, Novartis Pharma, Dr Reddys Laboratories Ltd, Wockhardt Pharma, Cipla, Glenmark Pharmaceuticals, Himalaya Company, USV Limited, Mylan Labs, Glaxo Company, Macleods Pharma, Ranbaxy Pharma, Torrent Pharmaceuticals, TCS etc.. etc.. etc..

<< ENQUIRE TODAY >>

Scope of GIRA Courses in RA/QA/QC:
· Adds on skills to your CV
· Higher opportunities for Jobs
· Updation of knowledge- A key to Successful Career
· Get Promoted to Higher levels

CONTACT :

Global Institute of Regulatory Affairs,
Office C5 and C6, Empire Estate,
Chinchwad, Mum- Pune Highway,
Near Premier Company,
Pune- 411019
Mob/ Tel: 9595 750 750/ 020- 4670 4472
Web: www.regulatoryinstitute.com
email: info@regulatoryinstitute.com
Blog: www.regulatoryinstitute.com/blog